ORBIMED ADVISORS LLC Insider Trading $GKOS GLAUKOS Corp

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ORBIMED ADVISORS LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in GLAUKOS Corp ($GKOS) and Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and in ACCELERON PHARMA INC ($XLRN) and Director in ProNAi Therapeutics Inc ($DNAI) and 10% Owner in AVEDRO INC ($AVDR) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in SI-BONE, Inc. ($SIBN) and Director in Xtant Medical Holdings, Inc. ($XTNT) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and Director in Otonomy, Inc. ($OTIC) and 10% Owner in Arsanis, Inc. ($ASNS) and 10% Owner in Principia Biopharma Inc. ($PRNB) and Director in Acutus Medical, Inc. ($AFIB) and Director in SYNLOGIC, INC. ($MIRN) and 10% Owner in NeuroPace Inc ($NPCE) and 10% Owner in GRAYBUG VISION, INC. ($GRAY) and 10% Owner in Sientra, Inc. ($SIEN) and 10% Owner in TELA Bio, Inc. ($TELA) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Dimension Therapeutics, Inc. ($DMTX) and 10% Owner in Guardant Health, Inc. ($GH) and 10% Owner in ViewRay, Inc. ($VRAY) and Director in ViewRay, Inc. ($VRAY) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and 10% Owner in Inspire Medical Systems, Inc. ($INSP) and Director in Inspire Medical Systems, Inc. ($INSP) and Director in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and Director in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Intellia Therapeutics, Inc. ($NTLA) and 10% Owner in Alector, Inc. ($ALEC) and Director in Alector, Inc. ($ALEC) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in NextCure, Inc. ($NXTC) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in IMARA Inc. ($IMRA) and Director in Keros Therapeutics, Inc. ($KROS) and Director in Prelude Therapeutics Inc ($PRLD) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in resTORbio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and Director in Edgewise Therapeutics, Inc. ($EWTX) and Director in 89bio, Inc. ($ETNB) and Director in Arcutis Biotherapeutics, Inc. ($ARQT) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Fusion Pharmaceuticals Inc. ($FUSN) and Director in Terns Pharmaceuticals, Inc. ($TERN) and Director in Ikena Oncology, Inc. ($IKNA).

ORBIMED ADVISORS LLC in GLAUKOS Corp

Trading Symbol: GKOS
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 562,839 shares
Current Value: $24,950,653
Latest Transaction: Mar 06 2018
$GKOS Market Capitalization: $1.51B
$GKOS Previous Close: $44.33

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in GLAUKOS Corp

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ETNB, XLRN, AFIB, ADAP, TORC, AGLE, ARPO, ALEC, ALPN, ARQT, ARMO, BOLD, AVDR, CNST, CRVS, CTIC, DBTX, DMTX, EWTX, FUSN, GKOS, GRAY, GH, IKNA, IMRA, INSP, NTLA, ICPT, KALA, KROS, KNTE, LOGC, LOXO, NPCE, NXTC, ORIC, OTIC, PIRS, PMVP, PRLD, PRVL, PRNB, RLYP, RPTX, RPBIF, RYTM, SCPH, SELB, SIBN, SIEN, SRRA, SBTX, ROKA, SWTX, STDY, SYBX, THOR, TELA, TERN, TCDA, TPTX, VRAY, ASNS, XTNT

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS32.0644514,2670445 to 0 (-100.00 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS32.0646,6761,496,433046.7 K to 0 (-100.00 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS30.771925,908445637 to 445 (-30.14 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS30.7720,114618,90846,67666.8 K to 46.7 K (-30.12 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS30.0188626,5896371.5 K to 637 (-58.17 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS30.0193,0082,791,17066,790159.8 K to 66.8 K (-58.20 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS33.0676825,3901,5232.3 K to 1.5 K (-33.52 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS33.0680,5162,661,859159,798240.3 K to 159.8 K (-33.50 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS32.051,22039,1012,2913.5 K to 2.3 K (-34.75 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS32.05128,0924,105,349240,314368.4 K to 240.3 K (-34.77 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS32.801,85160,7133,5115.4 K to 3.5 K (-34.52 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS32.80194,4336,377,402368,406562.8 K to 368.4 K (-34.55 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS31.922,53380,8535,3627.9 K to 5.4 K (-32.08 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS31.92265,7668,483,251562,839828.6 K to 562.8 K (-32.07 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS40.7755322,5467,8958.4 K to 7.9 K (-6.55 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS40.7758,0472,366,576828,605886.7 K to 828.6 K (-6.55 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS39.631,80871,6518,44810.3 K to 8.4 K (-17.63 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS39.63189,7927,521,457886,6521.1 M to 886.7 K (-17.63 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS37.941,65162,63910,25611.9 K to 10.3 K (-13.87 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS37.94173,3496,576,8611,076,4441.2 M to 1.1 M (-13.87 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS37.721,03839,15311,90712.9 K to 11.9 K (-8.02 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS37.72109,0404,112,9891,249,7931.4 M to 1.2 M (-8.02 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS37.8242416,03612,94513.4 K to 12.9 K (-3.17 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS37.8244,4981,682,9141,358,8331.4 M to 1.4 M (-3.17 %)
Aug 17 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS37.852,14080,99913,36915.5 K to 13.4 K (-13.80 %)
Aug 17 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS37.85224,7808,507,9231,403,3311.6 M to 1.4 M (-13.81 %)
Aug 17 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS38.0161923,52815,50916.1 K to 15.5 K (-3.84 %)
Aug 17 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS38.0164,9612,469,1681,628,1111.7 M to 1.6 M (-3.84 %)
Aug 17 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS38.2930711,75516,12816.4 K to 16.1 K (-1.87 %)
Aug 17 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS38.2932,1931,232,6701,693,0721.7 M to 1.7 M (-1.87 %)
Mar 14 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS44.5469931,13316,43517.1 K to 16.4 K (-4.08 %)
Mar 14 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS44.5473,4013,269,2811,725,2651.8 M to 1.7 M (-4.08 %)
Mar 14 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS46.13732317,13417.1 K to 17.1 K (-0.04 %)
Mar 14 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS46.1369331,9681,798,6661.8 M to 1.8 M (-0.04 %)
Mar 14 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS45.301,99890,50917,14119.1 K to 17.1 K (-10.44 %)
Mar 14 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS45.30208,7129,454,6541,799,3592 M to 1.8 M (-10.39 %)
Mar 14 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS45.9891542,07219,12920 K to 19.1 K (-4.56 %)
Mar 14 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS45.9896,1134,419,2762,008,0712.1 M to 2 M (-4.57 %)
Mar 07 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS47.0552624,74820,04420.6 K to 20 K (-2.56 %)
Mar 07 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS47.0555,2462,599,3242,104,1842.2 M to 2.1 M (-2.56 %)
Aug 12 2016GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS33.721334,48520,57020.7 K to 20.6 K (-0.64 %)
Aug 12 2016GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS33.7213,967470,9672,159,4302.2 M to 2.2 M (-0.64 %)
Aug 12 2016GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS33.631,51851,05020,70322.2 K to 20.7 K (-6.83 %)
Aug 12 2016GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS33.63159,3825,360,0172,173,3972.3 M to 2.2 M (-6.83 %)
Aug 12 2016GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS33.771,11337,58622,22123.3 K to 22.2 K (-4.77 %)
Aug 12 2016GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS33.77116,8253,945,1802,332,7792.4 M to 2.3 M (-4.77 %)
Aug 05 2016GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS30.594,010122,66623,33427.3 K to 23.3 K (-14.67 %)
Aug 05 2016GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS30.59420,99012,878,0842,449,6042.9 M to 2.4 M (-14.67 %)
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorOption ExerciseM7.652611,9970
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorOption ExerciseM7.6527,346209,1970
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorOption ExerciseC0.002,67200
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorOption ExerciseC0.00280,53100
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorOption ExerciseC0.001,59900
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorOption ExerciseC0.00167,89800
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorOption ExerciseC0.0022,92300
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorOption ExerciseC0.002,406,44100
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorPayment of ExerciseF18.001111,99827,34427.5 K to 27.3 K (-0.40 %)
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorBuyM0.00261027,45527.2 K to 27.5 K (+0.96 %)
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorPayment of ExerciseF18.0011,623209,2142,870,5932.9 M to 2.9 M (-0.40 %)
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorBuyM0.0027,34602,882,2162.9 M to 2.9 M (+0.96 %)
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorBuyC0.0027,194027,1940 to 27.2 K
Jun 30 2015GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorBuyC0.002,854,87002,854,8700 to 2.9 M

Page:   1